Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse

Duchenne muscular dystrophy is a severe X-linked hereditary disease caused by the absence of functional dystrophin. The dystrophin-deficient mdx-mouse strain is a widely used animal model for dystrophin-deficiency. Several therapeutic approaches for muscular dystrophy have been proposed by different laboratories. In order to compare the efficacy of these therapies in the mdx-mouse, it is essential to implement standardized protocols for the assessment of functional and histological parameters in this mouse model. Here, we determine that the minimal 'Feret's diameter' is a geometrical parameter that allows for reliable measure of muscle fiber cross-sectional size. Using this geometrical parameter we calculate variance coefficients of the muscle fiber size and provide reference values for the quantitative assessment of dystrophic symptoms in frequently investigated muscles of wild-type and mdx-mouse. In addition, we compare the variance coefficients of the muscle fiber size with the percentage of muscle fibers with centralized nuclei; another histological hallmark of muscular dystrophy.

[1]  E Brewer,et al.  Particle size determination by automated microscopical imaging analysis with comparison to laser diffraction. , 1995, Journal of pharmaceutical sciences.

[2]  K. Davies,et al.  Muscular Dystrophy—Reason for Optimism? , 2002, Cell.

[3]  J. Faulkner,et al.  Force and power output of fast and slow skeletal muscles from mdx mice 6‐28 months old , 2001, The Journal of physiology.

[4]  N. Curtin,et al.  THE mdx MOUSE SKELETAL MUSCLE MYOPATHY: II. CONTRACTILE PROPERTIES , 1988, Neuropathology and applied neurobiology.

[5]  L. Duchen,et al.  The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. , 1987, Brain : a journal of neurology.

[6]  N. Shibata,et al.  Morphologic difference of neuropil threads in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy: a morphometric study , 1997, Neuroscience Letters.

[7]  K. Moore,et al.  X chromosome-linked muscular dystrophy (mdx) in the mouse. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[8]  N. Isogai,et al.  The observation of endothelial cells in vein grafts by the en face silver staining method , 1991, Microsurgery.

[9]  C. Carlson,et al.  A noninvasive procedure to detect muscle weakness in the mdx mouse , 1990, Muscle & nerve.

[10]  M. S. Hudecki,et al.  Pre-clinical screening of drugs using the mdx mouse , 2000, Neuromuscular Disorders.

[11]  C. D. Bell,et al.  Histopathological changes in Duchenne muscular dystrophy. , 1968, Journal of the neurological sciences.

[12]  D. Shotton,et al.  Muscular dystrophy in the mdx mouse: Histopathology of the soleus and extensor digitorum longus muscles , 1987, Journal of the Neurological Sciences.

[13]  W. Kühnel,et al.  Automatic image analysis of the postnatal growth of axons and myelin sheaths in the tibial and peroneal nerves of the rabbit. , 2000, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[14]  H. Brinkmeier,et al.  76th ENMC International Workshop: pathophysiology and therapy in the mdx mouse 21–23 January 2000, Naarden, The Netherlands , 2002, Neuromuscular Disorders.

[15]  K. Davies,et al.  Pharmacological strategies for muscular dystrophy , 2003, Nature Reviews Drug Discovery.

[16]  C. Benhamou,et al.  Osteoclast cytomorphometry in patients with femoral neck fracture. , 1996, Pathology, research and practice.

[17]  Dongsheng Duan,et al.  Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy , 2002, Nature Medicine.

[18]  A. Sébille,et al.  mdx mice show progressive weakness and muscle deterioration with age , 1995, Journal of the Neurological Sciences.

[19]  G. Landini,et al.  Size dependent variation in the fractal dimensions of herpes simplex epithelial keratitis. , 1993, Current eye research.

[20]  G. Goldspink,et al.  Accumulation of collagen and altered fiber‐type ratios as indicators of abnormal muscle gene expression in the mdx dystrophic mouse , 1989, Muscle & nerve.

[21]  L. S. Wan,et al.  Measurement of the Particle Size of Tablet Excipients with the Aid of Video Recording , 1987, Pharmaceutical Research.

[22]  J. Gillis,et al.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse , 1999, Journal of Muscle Research & Cell Motility.

[23]  K. Hoyte,et al.  Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Sanes,et al.  Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin α2-deficient mice , 2001, Neuromuscular Disorders.

[25]  T. Partridge,et al.  THE mdx MOUSE SKELETAL MUSCLE MYOPATHY: I. A HISTOLOGICAL, MORPHOMETRIC AND BIOCHEMICAL INVESTIGATION , 1988, Neuropathology and applied neurobiology.